XAGE (Longevity Health Holdings) Cash And Cash Equivalents : $1.14 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Longevity Health Holdings Cash And Cash Equivalents?

Longevity Health Holdings's quarterly cash and cash equivalents increased from Mar. 2024 ($0.89 Mil) to Jun. 2024 ($2.20 Mil) but then stayed the same from Jun. 2024 ($2.20 Mil) to Sep. 2024 ($1.14 Mil).

Longevity Health Holdings's annual cash and cash equivalents increased from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.13 Mil) and increased from Dec. 2022 ($0.13 Mil) to Dec. 2023 ($2.91 Mil).

Longevity Health Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Longevity Health Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Health Holdings Cash And Cash Equivalents Chart

Longevity Health Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Cash And Cash Equivalents

0.01

0.13

2.91

Longevity Health Holdings Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash And Cash Equivalents	Get a 7-Day Free Trial						7.97	2.91	0.89	2.20	1.14

Longevity Health Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Longevity Health Holdings (NAS:XAGE) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Longevity Health Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Longevity Health Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Health Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Longevity Health Holdings Inc (NAS:XAGE) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203

Website

https://www.carmellcorp.com

Longevity Health Holdings Inc is a United States based bio-aesthetics company that utilizes the Secretome to support skin and hair health.

Executives

Richard A Upton	director	12 MIDDLE STREET, AMHERST NH 03031
Kathryn Gregory	director	305 THAYER POND ROAD, WILTON CT 06897
Patrick A Sturgeon	officer: CFO and Secretary	600 LEXINGTON AVENUE 33 FLOOR, NEW YORK NY 10022
David W Anderson	director	519 LYNMERE ROAD, BRYN MAWR PA 19010
Rajiv Shukla	director, 10 percent owner, officer: Chief Executive Officer	EMERALD VIEW SUITE 400, 2054 VISTA PARKWAY, WEST PALM BEACH FL 33411
Randolph W Hubbell	director, officer: President and CEO	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
William R Newlin	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Steven Bariahtaris	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Jaime Garza	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Janet Vargo	officer: VP Clinical Services	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Donna Godward	officer: Chief Quality Officer	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
James C Hart	officer: Chief Medical Officer	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
William Woodward	director	ANTHEM VENTURE PARTNERS, 225 ARIZONA AVENUE, SUITE 200, SANTA MONICA CA 90401
Darlene T Deremer	director	200 CENTRAL AVENUE, SUITE 1850, ST. PETERSBURG FL 33701
Ahac Sponsor Iii Llc	10 percent owner	1177 AVENUE OF THE AMERICAS, 5TH FLOOR, NEW YORK NY 10036